Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019–February 2020

References

• WHO. World Health Organization, Novel Coronavirus (2019-nCoV) Situation Report - 1 21 January 2020; 2020: 1–5.
   Google Scholar
• Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–452.
   PubMed Web of Science ®Google Scholar
• van Dorp L, Acman M, Richard D, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genetics Evol. 2020;83:104351.
   PubMed Web of Science ®Google Scholar
• Okba NMA, Muller MA, Li W, et al. Severe acute respiratory syndrome Coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020;26(7):1478–1488.
   PubMed Web of Science ®Google Scholar
• Deslandes A, Berti V, Tandjaoui-Lambotte Y, et al. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020;55(6):106006.
   PubMed Web of Science ®Google Scholar
• Basavaraju SV, Patton ME, Grimm K, et al. Serologic testing of US blood donations to identify severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020. Clin Infect Dis. 2021;72(12):e1004–e9.
   PubMed Web of Science ®Google Scholar
• Sebastiao CS, Neto Z, Martinez P, et al. Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola. PLoS One. 2021;16(3):e0249249.
   Web of Science ®Google Scholar
• Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081–2090.
   PubMed Web of Science ®Google Scholar
• Carrat F, Figoni J, Henny J, et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort. Eur J Epidemiol. 2021;36(2):219–222.
   PubMed Web of Science ®Google Scholar
• La Rosa G, Mancini P, Bonanno Ferraro G, et al. SARS-CoV-2 has been circulating in northern Italy since December 2019: evidence from environmental monitoring. Sci Total Environ. 2021;750:141711. doi:10.1016/j.scitotenv.2020.141711
   PubMed Web of Science ®Google Scholar
• Althoff KN, Schlueter DJ, Anton-Culver H, et al. Antibodies to SARS-CoV-2 in all of US research program participants, January 2-March 18, 2020. Clin Infect Dis. 2021. doi:10.1093/cid/ciab519.
   Web of Science ®Google Scholar
• Worobey M, Watts TD, McKay RA, et al. 1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North America. Nature. 2016;539(7627):98–101.
   Web of Science ®Google Scholar
• Thompson R. Pandemic potential of 2019-nCoV. Lancet Infect Dis. 2020;20(3):280.
   PubMed Web of Science ®Google Scholar
• Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;2020:929–936.
   Web of Science ®Google Scholar
• Arbeitman CR, Rojas P, Ojeda-May P, Garcia ME. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields. Nat Commun. 2021;12(1):5407.
   Web of Science ®Google Scholar
• Zhang Z, Zheng Y, Niu Z, et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021;28(9):2765–2777.
   PubMed Web of Science ®Google Scholar
• Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020;71(15):778–785.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody Responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–2034.
   PubMed Web of Science ®Google Scholar
• MINSA. Marcos da Resposta em Angola. Direcção nacional de saúde pública; 2021.
   Google Scholar
• Admou B, Hazime R, Brahim I, El Adib AR. Influencing factors of SARS-Cov2 spread in Africa. J Glob Health. 2020;10(2):020331.
   Web of Science ®Google Scholar
• Apolone G, Montomoli E, Manenti A, et al. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori. 2020;2020:300891620974755.
   Google Scholar
• Chapleau RR, Christian M, Connors B, et al. Early identification of SARS-CoV-2 emergence in the department of defense via retrospective analysis of 2019-2020 upper respiratory illness samples. Msmr. 2021;28(6):2–5.
   Google Scholar
• Prado T, Fumian TM, Mannarino CF, Maranhao AG, Siqueira MM, Miagostovich MP. Preliminary results of SARS-CoV-2 detection in sewerage system in Niteroi municipality, Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2020;115:e200196.
   Web of Science ®Google Scholar
• Cazzato G, Foti C, Colagrande A, et al. Skin manifestation of SARS-CoV-2: the Italian experience. J Clin Med. 2021;10:8.
   Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Zeichner SL. COVID-19 in children: initial characterization of the pediatric disease. Pediatrics. 2020;145:6.
   Web of Science ®Google Scholar
• Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:6.
   Web of Science ®Google Scholar
• Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095.
   PubMed Web of Science ®Google Scholar
• Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19? Journal of microbiology. Immunol Infection/Wei Mian Yu Gan Ran Za Zhi. 2020;53(3):371–372.
   Google Scholar
• Renegar KB, Small PA Jr, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004;173(3):1978–1986.
   PubMed Web of Science ®Google Scholar
• Nascimento J, Castro RRT, Nascimento J, Knoploch BB, Duque P, Neves MAO. Coinfection of SARS-CoV-2 and measles morbillivirus in a front-line health worker in Rio de Janeiro, Brasil. Rev Assoc Med Bras. 2020;66(8):1027–1029.
   Web of Science ®Google Scholar
• Alobo M. Strengthened health systems are needed to tackle COVID-19 in Africa. Nat Med. 2021;27(7):1126–1127.
   Web of Science ®Google Scholar
• Huang AT, Garcia-Carreras B, Hitchings MDT, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020;11(1):4704.
   PubMed Web of Science ®Google Scholar
• Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370(6522):1339–1343.
   PubMed Web of Science ®Google Scholar
• Patel EU, Bloch EM, Clarke W, et al. Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. J Clin Microbiol. 2021;59:2.
   Web of Science ®Google Scholar
• Saad M, Elsalamony R. Measles vaccines may provide partial protection against COVID-19. Int J Cancer Biomed Res. 2020;5(1):14–19.
   Google Scholar
• Ogata AF, Cheng CA, Desjardins M, et al. Circulating SARS-CoV-2 vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clin Infect Dis. 2021. doi:10.1093/cid/ciab465
   Web of Science ®Google Scholar